Atlas Trials

Axcella Health, Inc

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Axcella Health, Inc

RecordFirmDate
Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection (NCT05152849)Axcella Health, Inc2021-12-15
Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy (NCT04816916)Axcella Health, Inc2021-06-29
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis (NCT04880187)Axcella Health, Inc2021-05-07
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease (NCT04134299)Axcella Health, Inc2019-09-25
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04073407)Axcella Health, Inc2019-07-27
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency (NCT04147936)Axcella Health, Inc2019-03-30
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04073368)Axcella Health, Inc2018-12-03

Track Axcella Health, Inc automatically

Every clearance here is in the API, with alerts when new ones post.